EDGE THERAPEUTICS (EDGE) Covered Calls

You can sell covered calls on EDGE THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EDGE (prices last updated Thu 4:16 PM ET):

EDGE THERAPEUTICS (EDGE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.71 +0.04 0.70 0.71 212K - 0.0B
Covered Calls For EDGE THERAPEUTICS (EDGE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 2.5 0.00 0.71 0.0% 0.0%
Mar 15 2.5 0.00 0.71 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company is also developing EG-1964, as a prophylactic treatment for the management of chronic subdural hematoma to prevent recurrent bleeding on the surface of the brain; and EG-1965, for the prevention of post-operative atrial fibrillation. Edge Therapeutics, Inc. was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.